Robert Nelsen, Director, 10% Owner at Prime Medicine, Inc. (PRME), bought 3,030,300 shares at $3.30 ($10.0M) on 2025-08-01, disclosed to the SEC on 2025-08-01.
Open-market purchase of $10.0M PRME by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |
| NMRA | BUY | 2023-09-25 | $1.8M | — | Filing → |